D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 42 Citations 5,651 194 World Ranking 4257 National Ranking 92

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Virus
  • DNA

Her primary areas of study are Virology, Virus, Drug resistance, Genetics and Phylogenetics. Her work on Lentivirus as part of her general Virology study is frequently connected to Human T-lymphotropic virus, thereby bridging the divide between different branches of science. In her research, Glycan is intimately related to Mutation, which falls under the overarching field of Virus.

Her work carried out in the field of Drug resistance brings together such families of science as Regimen, Viral load, Didanosine, Combination therapy and Drug. Her study in Phylogenetics is interdisciplinary in nature, drawing from both Evolutionary biology, Molecular epidemiology and Phylogenetic tree. Her biological study deals with issues like Genetic variation, which deal with fields such as Genotype.

Her most cited work include:

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management (389 citations)
  • A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients. (132 citations)
  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach (114 citations)

What are the main themes of her work throughout her whole career to date?

Kristel Van Laethem mostly deals with Virology, Drug resistance, Genetics, Virus and Genotype. Her Virology research includes elements of Molecular biology, Reverse transcriptase and Immunology. She has researched Immunology in several fields, including Acquired immunodeficiency syndrome and Cohort.

Kristel Van Laethem has included themes like Bioinformatics, Regimen, Internal medicine, Genotyping and Drug in her Drug resistance study. Her research investigates the connection with Virus and areas like Glycosylation which intersect with concerns in Mannose. Her research in Genotype focuses on subjects like Integrase inhibitor, which are connected to Integrase.

She most often published in these fields:

  • Virology (70.00%)
  • Drug resistance (37.50%)
  • Genetics (22.50%)

What were the highlights of her more recent work (between 2013-2021)?

  • Drug resistance (37.50%)
  • Virology (70.00%)
  • Genotype (20.83%)

In recent papers she was focusing on the following fields of study:

Kristel Van Laethem focuses on Drug resistance, Virology, Genotype, Internal medicine and Genetics. Kristel Van Laethem interconnects Reverse transcriptase, Bioinformatics, Regimen, Computational biology and Drug in the investigation of issues within Drug resistance. Kristel Van Laethem combines subjects such as Protein structure, Concordance and Acquired immunodeficiency syndrome with her study of Virology.

Her work deals with themes such as Integrase inhibitor, Amino acid, Antibody and HIV Protease Inhibitor, which intersect with Genotype. Her studies deal with areas such as Transmission, Viral load and Antiretroviral therapy as well as Internal medicine. As part of the same scientific family, Kristel Van Laethem usually focuses on Genetics, concentrating on Evolutionary biology and intersecting with NS5A and Protease inhibitor.

Between 2013 and 2021, her most popular works were:

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe (102 citations)
  • Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis (86 citations)
  • The genealogical population dynamics of HIV-1 in a large transmission chain: bridging within and among host evolutionary rates. (66 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • DNA

The scientist’s investigation covers issues in Drug resistance, Genotype, Genetics, Immunology and Transmission. Her Drug resistance study integrates concerns from other disciplines, such as Regimen, Internal medicine and Drug. Her Genetics study combines topics in areas such as Evolutionary biology and Genetic diversity.

Her study looks at the relationship between Evolutionary biology and topics such as Virus, which overlap with Genotyping. The subject of her Viral load research is within the realm of Virology. Her Virology study combines topics from a wide range of disciplines, such as Pcr assay and Antiretroviral therapy.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)

563 Citations

Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh.
Lancet Infectious Diseases (2019)

186 Citations

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

Kristel Van Laethem;Andrea De Luca;Andrea Antinori;Antonello Cingolani.
Antiviral Therapy (2002)

183 Citations

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis.
Retrovirology (2009)

171 Citations

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev.
Clinical Infectious Diseases (2016)

165 Citations

Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120 A NEW THERAPEUTIC CONCEPT TO HIT THE ACHILLES HEEL OF HIV

Jan Balzarini;Kristel Van Laethem;Sigrid Hatse;Matheus Froeyen.
Journal of Biological Chemistry (2005)

156 Citations

Managing resistance to anti-HIV drugs: an important consideration for effective disease management.

Anne-Mieke Vandamme;Kristel Van Laethem;Erik De Clercq.
Drugs (1999)

147 Citations

Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes

Jan Balzarini;Kristel Van Laethem;Willy J. Peumans;Els J. M. Van Damme.
Journal of Virology (2006)

138 Citations

The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö.
Journal of Acquired Immune Deficiency Syndromes (2006)

138 Citations

Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus

Jan Balzarini;Kristel Van Laethem;Dirk Daelemans;Sigrid Hatse.
Journal of Virology (2007)

136 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kristel Van Laethem

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 127

Jan Balzarini

Jan Balzarini

KU Leuven

Publications: 69

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 47

Carlo Federico Perno

Carlo Federico Perno

University of Milan

Publications: 44

Dominique Schols

Dominique Schols

KU Leuven

Publications: 43

Anders Sönnerborg

Anders Sönnerborg

Karolinska Institute

Publications: 37

Charles A. Boucher

Charles A. Boucher

Erasmus University Rotterdam

Publications: 35

Robert W. Shafer

Robert W. Shafer

Stanford University

Publications: 35

Philippe Lemey

Philippe Lemey

KU Leuven

Publications: 32

Andrea De Luca

Andrea De Luca

University of Siena

Publications: 31

Diane Descamps

Diane Descamps

Université Paris Cité

Publications: 31

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 31

Erik De Clercq

Erik De Clercq

Rega Institute for Medical Research

Publications: 31

Antoine Gessain

Antoine Gessain

Institut Pasteur

Publications: 28

Thomas Lengauer

Thomas Lengauer

Max Planck Institute for Informatics

Publications: 27

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 26

Trending Scientists

Jan Chomicki

Jan Chomicki

University at Buffalo, State University of New York

Andrea Bassanini

Andrea Bassanini

Organisation For Economic Co-Operation and Development

Godfried T. Toussaint

Godfried T. Toussaint

New York University Abu Dhabi

Franc Forstneric

Franc Forstneric

University of Ljubljana

Namrata Vaswani

Namrata Vaswani

Iowa State University

Félix Hernández

Félix Hernández

Jaume I University

Wendell A. Lim

Wendell A. Lim

University of California, San Francisco

Ewa K. Zuba-Surma

Ewa K. Zuba-Surma

Jagiellonian University

Oleg Fedorov

Oleg Fedorov

University of Oxford

Alexander J. B. Zehnder

Alexander J. B. Zehnder

Swiss Federal Institute of Aquatic Science and Technology

Danilo Dragoni

Danilo Dragoni

Indiana University

Chris J. Harvey

Chris J. Harvey

National Oceanic and Atmospheric Administration

Peter S. Friedmann

Peter S. Friedmann

University of Southampton

Giuseppe Matarese

Giuseppe Matarese

University of Naples Federico II

William Lawson

William Lawson

Stony Brook University

Piers C. Emson

Piers C. Emson

Babraham Institute

Something went wrong. Please try again later.